However, BRCA1 carriers were more likely to have triple negative breast cancer (p=0.002) and BRCA2 carriers were more likely to have luminal B breast cancer tumors (p=0.000078). The gene discussed is BRCA2; the disease is triple-negative breast carcinoma.